KOICA donates Celltrion's Herzuma to Ukraine

KOICA donates Celltrion's Herzuma to Ukraine

Celltrion Healthcare Co. said on Monday that Herzuma (ingredient name: Trastuzumab) was dispatched to patients in Ukraine by the Korea International...

CJ applies to FDA for trials of immuno-anticancer drug candidate

CJ applies to FDA for trials of immuno-anticancer drug candidate

CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...

LegoChem Bio, Amgen sign ADC platform deal for up to $1.2 bn

LegoChem Bio, Amgen sign ADC platform deal for up to $1.2 bn

South Korean pharmaceutical firm LegoChem Biosciences Inc. said on Dec. 23 it has transferred the antibody-drug conjugates (ADC) technology platform...

Dong-A ST incorporates NeuroBo as subsidiary

Dong-A ST incorporates NeuroBo as subsidiary

Dong-A ST said on Friday that it would acquire American drug company NeuroBo Pharmaceuticals as a subsidiary.NeuroBo, located in Boston, is a Nasdaq...

S.Korean biopharmaceutical sector to see brisk M&As in H1, 2023

S.Korean biopharmaceutical sector to see brisk M&As in H1, 2023

An expert says the first half of next year will see the start of brisk M&As in biopharmaceuticals targeting strategic investors.Pyeon Jae-seong,...

Syntekabio launches new drug development platform STB Cloud in US

Syntekabio launches new drug development platform STB Cloud in US

Syntekabio,Inc., a South Korean artificial intelligence (AI) drug development company, said on Monday it has launched its cloud-based AI drug develo...

LG Chem in $95.5 million drug out-licensing deal with China’s Innovent

LG Chem in $95.5 million drug out-licensing deal with China’s Innovent

LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., and China’s biotech company Innovent Biologics have entered into a strategi...

Daewoong submits new drug applications for Fexuclue in 10 countries

Daewoong submits new drug applications for Fexuclue in 10 countries

South Korea's leading drug company Daewoong Pharmaceutical is accelerating its global expansion efforts for its 34th domestically developed drug Fex...

S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug

S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug

South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...

LG Chem confirms diabetes drug Zemidapa's efficacy in phase 3 trials

LG Chem confirms diabetes drug Zemidapa's efficacy in phase 3 trials

LG Chem Ltd. announced in a disclosure on Monday that it had confirmed superior efficacy in phase 3 clinical trials for the combined administration ...

New drug developer Onconic Therapeutics raises $20 mn in Series B

New drug developer Onconic Therapeutics raises  $20 mn in Series B

South Korean drug developer Onconic Therapeutics, announced on Friday that it raised 26 billion won ($19.9 million) in Series B funding, with cumula...

SK Biopharmaceuticals launches epilepsy drug in France

SK Biopharmaceuticals launches epilepsy drug in France

South Korean SK Biopharmaceuticals Co. said on Friday that its treatment of epilepsy "Cenobamate" has been approved for sale in France.The company l...

Korea approves Daewoong Pharmaceutical's diabetes drug

Korea approves Daewoong Pharmaceutical's diabetes drug

DAEWOONG PHARMACEUTICAL has received domestic approval for its diabetes drug Envlo with the active ingredient enavogliflozin, the second straight ye...

NPS shortlists 6 candidates for chief investment officer opening

NPS shortlists 6 candidates for chief investment officer opening

National Pension Service (NPS) of South Korea, the world’s third-largest pension fund managing 896.6 trillion won ($690.5 billion) as of end-S...

Spectrum to push back launch date of Hanmi-developed drug Poziotinib

Spectrum to push back launch date of Hanmi-developed drug Poziotinib

Hanmi Pharmaceutical Co. announced Friday that California-based Spectrum Pharmaceuticals Inc. received a Complete Response Letter (CRL) from the US ...

Tesla’s Musk names Korea among top candidate sites for Gigafactory

Tesla’s Musk names Korea among top candidate sites for Gigafactory

Tesla Inc. Chief Executive Elon Musk said on Wednesday that South Korea is among its top candidates to build in Asia another Gigafactory, the US ele...

Mezzion Pharma to try again for US FDA approval of drug

Mezzion Pharma to try again for US FDA approval of drug

South Korea's Mezzion Pharma will seek to get the oral medicine Udenafil to treat side effects from heart surgery, planning to clinical trials in th...

NPS narrows search for new CIO to two major candidates

NPS narrows search for new CIO to two major candidates

South Korea’s National Pension Service (NPS), the world’s third-largest pension fund managing 917.2 trillion won ($692 billion) in asset...

No more ineffective drugs due to resistance

No more ineffective drugs due to resistance

L-Base is a pharmaceutical startup specializing in developing drugs for those who become resistant to existing cancer treatments. This year, the Minis...

Moderna to stay ahead in mRNA technology: CSO Melissa Moore

Moderna to stay ahead in mRNA technology: CSO Melissa Moore

CAMBRIDGE, MA – The COVID-19 coronavirus disease has been a curse for many people and companies around the world over the past couple of years...

SillaJen shares jump as exchange maintains listing, allows resumed trade

SillaJen shares jump as exchange maintains listing, allows resumed trade

Shares in South Korea’s scandal-hit biotechnological company SillaJen Inc. soared on Thursday after the local exchange decided to maintain the...

Sanofi, Korean biotech Lemonex ink material transfer agreement

Sanofi, Korean biotech Lemonex ink material transfer agreement

South Korean biotech Lemonex Inc. has signed a material transfer agreement (MTA) with global pharmaceutical giant Sanofi S.A. to use the Korean bi...

Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum

Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum

South Korea’s Hanmi Pharmaceutical Co. said on Tuesday that Rolontis, an anti-cancer drug it has jointly developed with its US partner, has ob...

Lotte Card draws bid from Hana as key candidates back off

Lotte Card draws bid from Hana as key candidates back off

South Korea's Lotte Card Co. has drawn preliminary bids from Hana Financial Group, a leading banking group in the country, and two to three unidenti...

Korean bio firms look to pills, patches for people who fear needles

Korean bio firms look to pills, patches for people who fear needles

Getting shots of a drug or vaccine over a long period is not easy for many people.That's probably why global biopharmaceutical companies and biotech...

Celltrion Healthcare logs record-high Q2 revenue on back of Remsima

Celltrion Healthcare logs record-high Q2 revenue on back of Remsima

Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.’s global marketing affiliate, posted its record-high second-quar...

TiumBio inks licensing deal with China's Hansoh for endometriosis drug

TiumBio inks licensing deal with China's Hansoh for endometriosis drug

South Korean biotech TiumBio Co. has signed a technology transfer agreement of its endometriosis and uterine myoma treatment candidate with China&rs...

SK Biopharmaceuticals signs epilepsy drug deal with Brazil’s Eurofarma

SK Biopharmaceuticals signs epilepsy drug deal with Brazil’s Eurofarma

South Korea’s SK Biopharmaceuticals Co. has signed a deal to license out its technology for Cenobamate, an antiepileptic drug, to Brazil&rsquo...

Korean biotech firms fold COVID-19 therapeutics development businesses

Korean biotech firms fold COVID-19 therapeutics development businesses

A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...

1 in 4 biotech firms struggles with decreasing cash reserves

1 in 4 biotech firms struggles with decreasing cash reserves

South Korea’s biotechnology firms – public and private alike –  are facing increasingly negative financial conditions. T...

Samsung’s latest Galaxy Z foldables: Slimmest, lightest yet smarter with AI features S.Korea to overhaul retirement pension system, introduce competition for higher returns POSCO sells Chinese stainless steel JV to Chinese rival for $300 mn Hahn & Co. to award bonus shares to Namyang staff, retires $7.1 mn in shares   Seoul vows zero-tolerance measures against unfair stock trading